BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17513251)

  • 1. [Paraneoplastic pemphigus].
    Preisz K; Kárpáti S
    Orv Hetil; 2007 May; 148(21):979-83. PubMed ID: 17513251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
    Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic pemphigus.
    Yong AA; Tey HL
    Australas J Dermatol; 2013 Nov; 54(4):241-50. PubMed ID: 22759072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic pemphigus.
    Zhu X; Zhang B
    J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin.
    Mahoney MG; Aho S; Uitto J; Stanley JR
    J Invest Dermatol; 1998 Aug; 111(2):308-13. PubMed ID: 9699735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview.
    Maruta CW; Miyamoto D; Aoki V; Carvalho RGR; Cunha BM; Santi CG
    An Bras Dermatol; 2019; 94(4):388-398. PubMed ID: 31644609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
    Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
    J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic pemphigus in children and adolescents.
    Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
    Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus.
    Proby C; Fujii Y; Owaribe K; Nishikawa T; Amagai M
    J Invest Dermatol; 1999 Feb; 112(2):153-6. PubMed ID: 9989789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
    Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
    Tirado-Sánchez A; Bonifaz A
    Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.
    Anhalt GJ; Kim SC; Stanley JR; Korman NJ; Jabs DA; Kory M; Izumi H; Ratrie H; Mutasim D; Ariss-Abdo L
    N Engl J Med; 1990 Dec; 323(25):1729-35. PubMed ID: 2247105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic lymphocytic leukemia revealed by atypic pemphigus].
    Voisard J; Beylot-Barry M; Doutre M; Vergier B; Marrot F; Joly P; Beylot C
    Ann Dermatol Venereol; 2000 May; 127(5):492-5. PubMed ID: 10863179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing paraneoplastic pemphigus with keratotic skin lesions lacking anti-plakin antibodies from severe lichen planus.
    Shimokata-Isoe M; Hashimoto T; Hirose M; Shinada Y; Matsuo S; Munetsugu T; Koga H; Ishii N; Satoh T
    Eur J Dermatol; 2021 Apr; 31(2):273-275. PubMed ID: 33871365
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis.
    Hashimoto T; Amagai M; Watanabe K; Chorzelski TP; Bhogal BS; Black MM; Stevens HP; Boorsma DM; Korman NJ; Gamou S
    J Invest Dermatol; 1995 May; 104(5):829-34. PubMed ID: 7738363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic pemphigus. Induction of autoantibodies against structural proteins in the skin].
    Zillikens D; Bröcker EB
    Hautarzt; 1994 Dec; 45(12):827-33. PubMed ID: 7843961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
    Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
    J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pemphigus].
    Lapeyre-Liénard H; Joly P
    Presse Med; 2010 Oct; 39(10):1066-70. PubMed ID: 20817387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
    Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
    Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.
    Probst C; Schlumberger W; Stöcker W; Recke A; Schmidt E; Hashimoto T; Zhu XJ; Zillikens D; Komorowski L
    Clin Chim Acta; 2009 Dec; 410(1-2):13-8. PubMed ID: 19737550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.